- N-Acetyl procainamide
drugbox
N-acetylprocainamide
IUPAC_name = 4-acetylamino-"N"-(2-diethylaminoethyl)benzamide
CAS_number = 32795-44-1
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 4342
DrugBank =
C=15|H=23|N=3|O=2
molecular_weight = 277.36 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
pregnancy_category =
legal_status =
routes_of_administration = intravenously or orally"N"-Acetylprocainamide (NAPA) (or acecainide) is the N-acetylated
metabolite ofprocainamide . It is a Class III antiarrhythmic agent.It can be given either intravenously or orally, and is eliminated primarily by renal excretion. Comparative studies with other antiarrhythmic drugs have not been undertaken apart from a small study in atrial flutter where acecainide was better than quinidine plus digoxin. Thus, although further clinical experience is required before the relative place of acecainide in therapy can be determined, the drug nevertheless appears to offer advantages over procainamide, particularly with respect to the reduced formation of antinuclear antibodies.
References
*"Merck Index", 13th Edition, 20.
*Ger. Pat. , 1971, 2 062 978; CA , 75 , 76427, (Acecainide)
Wikimedia Foundation. 2010.